Onyx Pharmaceuticals Announces 2013 Updates and Reviews 2012 Achievements at J.P. Morgan Healthcare Conference

Onyx Pharmaceuticals Announces 2013 Updates and Reviews 2012 Achievements at J.P. Morgan Healthcare Conference

[at noodls] – Kyprolisâ„¢ (carfilzomib) for Injection Net Sales Exceed $62 Million for 2012 South San Francisco, CA. – Jan. 07, 2013 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today reviewed 2012 accomplishments and announced … more

View todays social media effects on ONXX

View the latest stocks trending across Twitter. Click to view dashboard

See who ONYX is hiring next, click here to view

Share this post

Comments (0)